Abstract
Methadone maintenance treatment is proven to be effective treatment for opioid dependence. Of the many adverse events reported, sexual dysfunction is one of the most common side effects. However, there may be other clinical factors that are associated with sexual dysfunction among methadone users. We conducted a meta-analysis to examine the clinical factors associated with sexual dysfunction among male patients on methadone and buprenorphine treatments, of which eligible studies were selected using prior defined criteria. A total of 2619 participants from 16 eligible studies, published from inception till December 2012, were identified from the PubMed, OVID and EMBASE databases. The included studies provided prevalence estimates for sexual dysfunction among methadone users with a meta-analytical pooled prevalence of 52% (95% confidence interval (CI), 0.39–0.65). Only four studies compared sexual dysfunction between the two groups, with a significantly higher combined odds ratio in the methadone group (odds ratio=4.01, 95% CI, 1.52–10.55, P=0.0049). Our study shows that eight clinical factors are associated with sexual dysfunction among men receiving opioid substitution treatment, namely age, hormone assays, duration of treatment, methadone dose, medical status, psychiatric illness, other current substance use and familial status, and methadone versus buprenorphine treatment. Despite the methodological limitations, the findings of this meta-analysis study may offer better insights to clinicians in dealing with both sexual dysfunction and its related problems.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States. JAMA 1999; 281: 537–544.
Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction case–control study. Br J Psychiatry 2003; 182: 50–56.
Rosen RC . Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000; 2: 189–195.
Grube M, Weigand-Tomiuk H . Sexual dysfunctions in a group of psychiatric in-patients]. Psychiatrische Praxis 2002; 29: 194.
Oksuz E, Malhan S . The prevalence of male sexual dysfunction and potential risk factors in Turkish men: a Web-based survey. Int J Impot Res 2005; 17: 539–545.
Mattick RP, Breen C, Kimber J, Davoli M . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; CD002209.
Teusch L, Scherbaum N, Böhme H, Bender S . Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment: results of an investigation by semi-structured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995; 28: 84–92.
Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E . Function of the male sex organs in heroin and methadone users. N Engl J Med 1975; 292: 882–887.
Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J . Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sexual Med 2008; 5: 684–692.
Patricia A, Cioe R, Peter D, Friedmann M, Stein MD . Erectile dysfunction in opioid users: lack of association with serum testosterone. J Addict Dis 2010; 29: 455–460.
Brown R, Balousek S, Mundt M, Michael Fleming MDM . Methadone maintenance and male sexual dysfunction. J Addict Dis 2005; 24: 91–106.
Chen W, Li X, Li X, Ling L, Xia Y, Chen J et al. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China. J Addict Med 2012; 6: 212–218.
Zhang Y, Wang P, Ma Z, Xu Z, Li Y . Sexual function of 612 male addicts treated by methadone. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011; 36: 739.
Nik Jaafar NR, Mislan N, Abdul Aziz S, Baharudin A, Ibrahim N, Midin M et al. Risk factors of erectile dysfunction in patients receiving methadone maintenance therapy. J Sexual Med 2013; 10: 2069–2076.
Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D . Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005; 90: 203–206.
Giacomuzzi S, Khreis A, Riemer Y, Garber K, Ertl M . Buprenorphine and methadone maintenance treatment-sexual behaviour and dysfunction prevalence. Lett Drug Design Discov 2009; 6: 13-.
Tatari F, Farnia V, Najafi F . Trazodone in methandone induced erectile dysfunction. Iran J Psychiatry 2010; 5: 164–166.
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160–174.
Chekuri V, Gerber D, Brodie A, Krishnadas R . Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addict Behav 2012; 37: 124–126.
Hanbury R, Cohen M, Stimmel B . Adequacy of sexual performance in men maintained on methadone. Am J Drug Alcohol Abuse 1977; 4: 13–20.
Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC . Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug and Alcohol Depen 2008; 94: 12–18.
Baharudin A, Mislan N, Ibrahim N, Sidi H, Nik Jaafar NR . Depression in male patients on methadone maintenance therapy. Asia-Pacific Psychiatry 2013; 5: 67–73.
Spring WD, Willenbring ML, Maddux TL . Sexual dysfunction and psychological distress in methadone maintenance. Subst Use Misuse 1992; 27: 1325–1334.
Peugh J, Belenko S . Alcohol, drugs and sexual function: a review. J Psychoactive Drugs 2001; 33: 223–232.
Emanuele MA, Emanuele NV . Alcohol’s effects on male reproduction. Alcohol Health Res World 1998; 22: 195–201.
Colameco S, Coren JS . Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009; 109: 20–25.
Peate I . The effects of smoking on the reproductive health of men. Br J Nurs 2005; 14: 362–367.
Fronczak CM, Kim ED, Barqawi AB . The insults of illicit drug use on male fertility. J Androl 2012; 33: 515–528.
Moher D, Liberati A, Tetzlaff J, Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
McAnulty RD, Burnette MM . Sex and sexuality. Greenwood Publishing Group, 2006.
Lofwall MR, Stitzer ML, Bigelow GE, Strain EC . Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence. Addict Disord Treat 2005; 4: 49–64.
Yule M, Davison J, Brotto L . The international index of erectile function: a methodological critique and suggestions for improvement. J Sex Marital Ther 2011; 37: 255–269.
Rosen D, Smith ML, Reynolds CF III . The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatric Psych 2008; 16: 488–497.
Mendelson JH, Mendelson JE, Patch VD . Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 1975; 192: 211–217.
Mendelson J, Meyer R, Ellingboe J, Mirin S, McDougle M . Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975; 195: 296–302.
Woody G, McLellan A, O’Brien C, Persky H, Stevens G, Arndt I et al. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monogr 1988; 81: 216–223.
Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J . Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 2009; 32: 131–139.
Xia Y, Zhang D, Li X, Chen W, He Q, Jahn HJ et al. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China. Psychol Health Med 2013; 18: 321–329.
Daniell HW . Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict dis 2002; 21: 47–53.
Colameco S, Coren JS, Zimmerman DJ . Buprenorphine-induced symptomatic hypogonadism in men: case reports and discussion. J Addict Med 2008; 2: 147–150.
Dürsteler-MacFarland KM, Fischer DA, Mueller S, Schmid O, Moldovanyi A, Wiesbeck GA . Symptom complaints of patients prescribed either oral methadone or injectable heroin. J Subs Abuse Treat 2010; 38: 328–337.
Grönbladh L, Öhlund LS . Self-reported differences in side-effects for 110 heroin addicts during opioid addiction and during methadone treatment. Heroin Addict Relat Clin Probl 2011; 13: 5–12.
Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP et al. The medical status of methadone maintenance patients in treatment for 11–18 years. Drug Alcohol Depend 1993; 33: 235–245.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yee, A., Loh, H., Hisham Hashim, H. et al. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study. Int J Impot Res 26, 161–166 (2014). https://doi.org/10.1038/ijir.2014.18
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2014.18
This article is cited by
-
Unerwünschte Wirkungen von Opioiden, Antidepressiva und Antikonvulsiva auf Sexualhormone
Der Schmerz (2022)
-
Antiandrogene Wirkungen von Opioiden
Schmerzmedizin (2021)
-
Sexual Dysfunction in Persons Receiving Opioid Substitution Therapy
Current Sexual Health Reports (2020)
-
Opioid-Related Sexual Dysfunction in Men
Current Sexual Health Reports (2018)